Prostate cancer (PCa) ranks as the second most prevalent malignancy among men worldwide. Early diagnosis, personalized treatment, and prognosis prediction of PCa play a crucial role in improving patients' survival rates. The advancement of artificial intelligence (AI), particularly the utilization of deep learning (DL) algorithms, has brought about substantial progress in assisting the diagnosis, treatment, and prognosis prediction of PCa. The introduction of the foundation model has revolutionized the application of AI in medical treatment and facilitated its integration into clinical practice. This review emphasizes the clinical application of AI in PCa by discussing recent advancements from both pathological and imaging perspectives. Furthermore, it explores the current challenges faced by AI in clinical applications while also considering future developments, aiming to provide a valuable point of reference for the integration of AI and clinical applications.
Humans ; Prostatic Neoplasms/diagnosis* ; Male ; Artificial Intelligence ; Deep Learning ; Prognosis

In recent years, the ongoing development of transcranial electrical stimulation (TES) and transcranial magnetic stimulation (TMS) has demonstrated significant potential in the treatment and rehabilitation of various brain diseases. In particular, the combined application of TES and TMS has shown considerable clinical value due to their potential synergistic effects. This paper first systematically reviews the mechanisms underlying TES and TMS, highlighting their respective advantages and limitations. Subsequently, the potential mechanisms of transcranial electromagnetic combined stimulation are explored, with a particular focus on three combined stimulation protocols: Repetitive TMS (rTMS) with transcranial direct current stimulation (tDCS), rTMS with transcranial alternating current stimulation (tACS), and theta burst TMS (TBS) with tACS, as well as their clinical applications in brain diseases. Finally, the paper analyzes the key challenges in transcranial electromagnetic combined stimulation research and outlines its future development directions. The aim of this paper is to provide a reference for the optimization and application of transcranial electromagnetic combined stimulation schemes in the treatment and rehabilitation of brain diseases.
Humans ; Transcranial Magnetic Stimulation/methods* ; Transcranial Direct Current Stimulation/methods* ; Brain Diseases/therapy*

Off-label drug use in psychiatry has long been prevelent, with common clinical practices lacking standardized guidance and associated risks warranting close attention. To address the practical needs of frontline clinicians, the Mental Health Branch of the China National Narcotic Drugs Association, in collaboration with multiple institutions, has launched a project to formulate the Guidelines on Off-label Use of Common Psychiatric Medications in China ("Guideline"). The Guidelines focuses on evaluating evidence and formulating recommendations regarding off-label use scenarios of common psychiatric medications, including indications, dosage, administration, and specific populations. It employs standard methodological frameworks, notably the GRADE-ADOLOPMENT approach (Grading of Recommendations Assessment, Development, and Evaluation Evidence to Decision frameworks for adoption, adaptation, and de?novo development of recommendations), to ensure both scientific rigor and practical applicability. This proposal systematically outlines the background, objectives, processes, organizational structure, and methodologies of the Guideline, aiming to provide psychiatrists with practical and evidence-based prescribing recommendations.

Objective:To evaluate the feasibility of transjugular transcatheter tricuspid valve replacement (TTVR) using the LuX-Valve Plus system (Ningbo Jenscare Scientific, China) for the treatment of severe tricuspid regurgitation in real-world clinical settings.Methods:This prospective study enrolled 81 patients with severe ricuspid regurgitation (≥3+) who underwent TTVR with the LuX-Valve Plus system at the Department of Cardiology, West China Hospital of Sichuan University between May 2022 and March 2024. Among them, 44 patients were from a compassionate-use study, and 37 were from two premarket clinical trials. Baseline clinical data, preprocedural imaging, procedural outcomes, and postprocedural follow-up data were collected. The primary endpoint events included device success, procedural success, and 30 d composite adverse events.Results:The age of the cohort was (74.5±7.8) years, with 54 females (67%). Device success and procedural success rates were both 90% (73/81). Post-procedural tricuspid regurgitation improved, with a 6% (5/81) incidence of moderate-to-severe paravalvular leakage. The rate of permanent pacemaker implantation was 12% (10/81), of which 5% (4/81) had pre-existing indications for pacemaker implantation. Major bleeding events occurred in 10% (8/81) of patients, and the 30 d composite endpoint rate was 25% (20/81).Conclusion:TTVR using the LuX-Valve Plus system demonstrates promising feasibility for high-risk surgical patients with severe tricuspid regurgitation, effectively reducing or eliminating regurgitation with acceptable safety. However, challenges remain in reducing risks of major adverse events, including permanent pacemaker implantation and severe bleeding.

Off-label drug use in psychiatry has long been prevelent, with common clinical practices lacking standardized guidance and associated risks warranting close attention. To address the practical needs of frontline clinicians, the Mental Health Branch of the China National Narcotic Drugs Association, in collaboration with multiple institutions, has launched a project to formulate the Guidelines on Off-label Use of Common Psychiatric Medications in China ("Guideline"). The Guidelines focuses on evaluating evidence and formulating recommendations regarding off-label use scenarios of common psychiatric medications, including indications, dosage, administration, and specific populations. It employs standard methodological frameworks, notably the GRADE-ADOLOPMENT approach (Grading of Recommendations Assessment, Development, and Evaluation Evidence to Decision frameworks for adoption, adaptation, and de?novo development of recommendations), to ensure both scientific rigor and practical applicability. This proposal systematically outlines the background, objectives, processes, organizational structure, and methodologies of the Guideline, aiming to provide psychiatrists with practical and evidence-based prescribing recommendations.

Objective:To evaluate the feasibility of transjugular transcatheter tricuspid valve replacement (TTVR) using the LuX-Valve Plus system (Ningbo Jenscare Scientific, China) for the treatment of severe tricuspid regurgitation in real-world clinical settings.Methods:This prospective study enrolled 81 patients with severe ricuspid regurgitation (≥3+) who underwent TTVR with the LuX-Valve Plus system at the Department of Cardiology, West China Hospital of Sichuan University between May 2022 and March 2024. Among them, 44 patients were from a compassionate-use study, and 37 were from two premarket clinical trials. Baseline clinical data, preprocedural imaging, procedural outcomes, and postprocedural follow-up data were collected. The primary endpoint events included device success, procedural success, and 30 d composite adverse events.Results:The age of the cohort was (74.5±7.8) years, with 54 females (67%). Device success and procedural success rates were both 90% (73/81). Post-procedural tricuspid regurgitation improved, with a 6% (5/81) incidence of moderate-to-severe paravalvular leakage. The rate of permanent pacemaker implantation was 12% (10/81), of which 5% (4/81) had pre-existing indications for pacemaker implantation. Major bleeding events occurred in 10% (8/81) of patients, and the 30 d composite endpoint rate was 25% (20/81).Conclusion:TTVR using the LuX-Valve Plus system demonstrates promising feasibility for high-risk surgical patients with severe tricuspid regurgitation, effectively reducing or eliminating regurgitation with acceptable safety. However, challenges remain in reducing risks of major adverse events, including permanent pacemaker implantation and severe bleeding.

Oral diseases concern almost every individual and are a serious health risk to the popula-tion.The restorative treatment of tooth and jaw defects is an important means to achieve oral function and support the appearance of the contour.Based on the principle of"learning from the nature",Deng Xu-liang's group of Peking University School and Hospital of Stomatology has proposed a new concept of"microstructural biomimetic design and tissue adaptation of tooth/jaw materials"to address the worldwide problems of difficulty in treating dentine hypersensitivity,poor prognosis of restoration of tooth defects,and vertical bone augmentation of alveolar bone after tooth loss.The group has broken through the bottle-neck of multi-stage biomimetic technology from the design of microscopic features to the enhancement of macroscopic effects,and invented key technologies such as crystalline/amorphous multi-level assembly,ion-transportation blocking,and multi-physical properties of the micro-environment reconstruction,etc.The group also pioneered the cationic-hydrogel desensitizer,digital stump and core integrated restora-tions,and developed new crown and bridge restorative materials,gradient functionalisation guided tissue regeneration membrane,and electrically responsive alveolar bone augmentation restorative membranes,etc.These products have established new clinical strategies for tooth/jaw defect repair and achieved inno-vative results.In conclusion,the research results of our group have strongly supported the theoretical im-provement of stomatology,developed the technical system of oral hard tissue restoration,innovated the clinical treatment strategy,and led the progress of the stomatology industry.

Exosomes are extracellular vesicles that are released from the cell into the extracellular microenvironment,and are a carrier of biological information transmitted over long distances,which have a dual regulatory effect on the immune system.Studies have shown that viruses can hold the endosomal-exosomal pathway hostage to spread.This review describes the role played by exosomes in viral infections.On the one hand,exosomes can transmit antiviral substances and trigger im-mune responses against viral infections,and on the other hand,exosomes can serve as potential mediators of viral transmis-sion,which have been shown to be closely related to the transmission and immune escape of a variety of viruses.Understand-ing the role of exosomes in viral infections is essential for the detection of viruses in the blood,for improving blood safety,and for the search and development of antiviral drugs.

Objective To observe the application effect of polyhexamethylene biguanide (PHMB) antibacterial dressing in the treatment of skin ulcer around the stoma in patients with enterostomy during radiotherapy and chemotherapy. Methods A total of 65 patients with skin ulcer around the stoma during radiotherapy and chemotherapy were randomly divided into control group (34 cases) and observation group (31 cases). The control group was treated with silver ion dressing for skin ulcer around the stoma, while the observation group was treated with PHMB antibacterial dressing around the stoma. The healing rate of skin ulcer around the stoma, frequency of average dressing change, dressing cost at 4 weeks after treatment as well as Discoloration, Erosion, Tissue overgrowth (DET) score and ulcer status around the stoma were compared between the two groups at 2 and 4 weeks after treatment. Results The healing rate of skin ulcer around the stoma in the observation group was (70.68±6.39)% at 4 weeks of treatment, which was higher than (57.76±12.82)% in the control group, and the dressing cost was less than that in the control group within 4 weeks (P < 0.05). There was no significant difference in the average dressing change frequency between the two groups within 4 weeks (P>0.05). At 2 and 4 weeks of treatment, the DET score and ulcer area around the stoma in the observation group were lower or smaller than those in the control group (P < 0.05). Conclusion The use of PHMB antibacterial dressing in the treatment of skin ulcer around the stoma in patients with enterostomy during radiotherapy and chemotherapy can effectively control infection, promote ulcer healing, and has excellent economic cost-effectiveness.

Corona virus disease 2019 (COVID-19) is an acute respiratory infectious disease with strong contagiousness, strong variability, and long incubation period. The probability of misdiagnosis and missed diagnosis can be significantly decreased with the use of automatic segmentation of COVID-19 lesions based on computed tomography images, which helps doctors in rapid diagnosis and precise treatment. This paper introduced the level set generalized Dice loss function (LGDL) in conjunction with the level set segmentation method based on COVID-19 lesion segmentation network and proposed a dual-path COVID-19 lesion segmentation network (Dual-SAUNet++) to address the pain points such as the complex symptoms of COVID-19 and the blurred boundaries that are challenging to segment. LGDL is an adaptive weight joint loss obtained by combining the generalized Dice loss of the mask path and the mean square error of the level set path. On the test set, the model achieved Dice similarity coefficient of (87.81 ± 10.86)%, intersection over union of (79.20 ± 14.58)%, sensitivity of (94.18 ± 13.56)%, specificity of (99.83 ± 0.43)% and Hausdorff distance of 18.29 ± 31.48 mm. Studies indicated that Dual-SAUNet++ has a great anti-noise capability and it can segment multi-scale lesions while simultaneously focusing on their area and border information. The method proposed in this paper assists doctors in judging the severity of COVID-19 infection by accurately segmenting the lesion, and provides a reliable basis for subsequent clinical treatment.
Humans ; COVID-19/diagnostic imaging* ; Respiratory Rate ; Tomography, X-Ray Computed